Patrick Forde
@FordePatrick
Followers
6K
Following
7K
Statuses
3K
Lung cancer & Mesothelioma. Immunotherapy believer. 🇮🇪 🇺🇸
Joined June 2019
Patient-centered summary of the #CheckMate816 neoadjuvant chemo-immunotherapy clinical trial. This is a new treatment for patients with stage 1-3 non-small-cell lung cancer that can be removed by surgery. The summary may be useful for clinicians & patients. #lcsm @LUNGevity
13
114
311
Air pollution causing 1,100 cases a year of main form of lung cancer in UK | Lung cancer | The Guardian
0
3
16
RT @CharlesJiangMD: Fellow oncologists – check out my free visualization tool for adjuvant therapy risks & benefit discussion. It's built f…
0
15
0
Colleagues in the US of A, who is gong to come for the visit? #LCSM
1
1
6
@gerryhanna @JCO_ASCO @fifimcdrmh @DrewMoghanaki @finn_corinne @_ShankarSiva @gwalls89 @DavidDbal @cpeedell @Mat_Guc @DrJNaidoo I have recommended/pushed for local therapy like this fairly frequently, mainly with single metastasis but occasionally with two or with oligopersistence/oligoprogression. Issues that come up are when do you do the local therapy and when (if ever) do you stop the TKI..
0
0
8
RT @gerryhanna: Delighted to celebrate my inaugural lecture @tcddublin #SLRON @CancerInstIRE with family and friends Was pleased to honour…
0
9
0
Lung cancer diagnoses on the rise among never-smokers worldwide | Lung cancer | The Guardian
0
30
63
RT @MARIANOPROVENCI: At GECP, we have an academic phase II clinical trial with the NADIM regimen as induction therapy for Pancoast Tumor. S…
0
4
0
Elegant work from Drs. Zeng, Ji and @SmithImmunology and an open source resource for the scientific community!
We developed a 3-gene signature to identify tumor-specific CD8 TIL, i.e. the cells targeted by #immunotherapy, from #singlecell data. Out now in @NatureComms. All data & code are public. Please use it! #WomenInSTEM #science #research #datascience #AI
1
0
2
@ElliotServaisMD @DrewMoghanaki @tedbill18 @NateEvansMD @RajaFlores @LindaMThoracic @DoctorJSpicer @StephenVLiu @SBroderickMD @BrendonStilesMD @jdoningtonmd @TomVargheseJr @MARIANOPROVENCI Although the local/in chest recurrence rate seems unaltered by adding IO to neoadj chemo, do you that’s because surgeons are being more ambitious after neoadj chemo-IO or perhaps a learning curve and it may improve over time?
1
0
3
@DrewMoghanaki @tedbill18 @ElliotServaisMD @NateEvansMD @RajaFlores @LindaMThoracic @DoctorJSpicer @StephenVLiu @SBroderickMD @BrendonStilesMD @jdoningtonmd @TomVargheseJr @MARIANOPROVENCI The more I hear these discussions the more I think the fundamentals need to be retested, maybe chemo-IO then radiation then surgery is best? Essentially chemo-IO is a very different therapy to chemo so how can we assume 20-30yo paradigms built on chemo still hold.
2
0
6
RT @Latinamd: #WLC25 @SusanScottMD @HopkinsThoracic knocked it out of the park⚾️🏟️winning 🥇argument that osimertinib monotherapy is no long…
0
11
0
Thanks for an amazing last day in Gran Canaria arranged by Wendy & Delvys @delvysra a memorable end to a great meeting!
1
1
48
Dr. @PrelajArsela with an outstanding review of where AI stands in lung cancer including several multi center studies that she is leading #lcsm
#itcd2025
1
6
30
RT @StephenVLiu: As #ITCD2025 closes, grateful for the chance to learn from the top lung cancer experts as we share different perspectives…
0
11
0
Dr. @BenCreelan who has pioneered cell therapy for NSCLC, gives a great talk on TIL/cell therapy, always seems to be on horizon but hopefully getting closer #ITCD2025
2
12
40
RT @FCCPulmon: The first presentation of the day is delivered by Dr. @FordePatrick from St. James Hospital, Trinity College Dublin. The top…
0
3
0
Dr. @peters_solange with an outstanding overview of novel IO-IO combinations in advanced NSCLC #ITCD2025
1
7
31
Now Dr. @MartinReck2 on 2nd line advanced NSCLC, also more failures than successes recently, we need to keep trying! #ITCD2025
0
6
28